Find a Research Study

Sogroya (somapacitan) is a medicine that replaces growth hormone in adults whose bodies do not produce enough of it. It is approved by the FDA and is used to treat growth hormone deficiency. People who take Sogroya may have better heart health, less body fat, more muscle, and more energy for physical activity. Researchers still want to learn more about the long-term effects of Sogroya, including if it affects a person’s cancer and diabetes risk. This study will look at how safe Sogroya is and how well it works in people who are taking it now or plan to start taking it. If you join this study, you will continue to see your doctor during your regular clinic visits. At each visit, your doctor will ask if you have had any side effects from Sogroya. You will also fill out two short questionnaires that ask about your health, daily activities, and work. These surveys will take about 10 to 15 minutes to finish. You and your insurance will need to pay for routine medical care. You will be paid $50 for each clinic visit you attend. You may be in the study for 5 to 10 years.

Who can Participate

You may be able to join this study if you are at least 18 years old, have growth hormone deficiency, and are currently being treated or plan to start treatment with Sogroya (somapacitan).

Study ID

More information available at ClinicalTrials.gov: NCT05718570